CD19 and neoplasm: Conversely, adoptive transfer of CD19.4–1BB CAR-T cells was associated with a significantly greater frequency of initial tumor growth, but of note, there were fewer relapses as compared to mice treated with CD19.CD28 CAR-T cells.